NCT02359097 Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma Status COMPLETED Phase NA
NCT02345824 Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma Status UNKNOWN Phase PHASE1
NCT02343406 Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas Status COMPLETED Phase PHASE2
NCT02336165 Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma Status COMPLETED Phase PHASE2
NCT02330991 A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse Status COMPLETED Phase PHASE2
NCT02330562 Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab Status COMPLETED Phase PHASE1/PHASE2
NCT02329795 Image-derived Prediction of Response to Chemo-radiation in Glioblastoma Status TERMINATED Phase N/A
NCT02327078 A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) Status COMPLETED Phase PHASE1/PHASE2
NCT02315534 A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT02287428 Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02254954 Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma Status TERMINATED Phase PHASE1
NCT02238496 Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas Status COMPLETED Phase PHASE1
NCT02209948 Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma. Status COMPLETED Phase PHASE2
NCT02206230 Trial of Hypofractionated Radiation Therapy for Glioblastoma Status COMPLETED Phase PHASE2